Materials & Resources » Chemicals | Yifan Pharmaceutical Co. Ltd.

Yifan Pharmaceutical Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
693
1,672
2,416
3,455
4,312
4,581
Cost of Goods Sold (COGS) incl. D&A
515
1,021
1,475
1,770
1,912
2,648
Gross Income
178
651
941
1,684
2,400
1,933
SG&A Expense
111
343
541
732
800
965
EBIT
62
304
382
943
1,588
956
Unusual Expense
5
5
1
19
27
60
Non Operating Income/Expense
7
2
18
16
37
8
Interest Expense
28
5
23
56
91
64
Pretax Income
27
301
445
895
1,536
891
Income Tax
1
63
82
211
265
191
Equity in Affiliates
-
-
-
-
6
6
Consolidated Net Income
26
238
362
683
1,266
694
Net Income
26
238
361
705
1,305
737
Net Income After Extraordinaries
26
238
361
705
1,305
737
Net Income Available to Common
26
238
361
705
1,305
737
EPS (Basic)
0.05
0.35
0.33
0.64
1.15
0.61
Basic Shares Outstanding
551
684
1,101
1,101
1,136
1,207
EPS (Diluted)
0.05
0.35
0.33
0.64
1.15
0.61
Diluted Shares Outstanding
551
684
1,101
1,101
1,136
1,207
EBITDA
115
326
456
1,035
1,700
1,085
Other Operating Expense
5
4
18
9
12
12
Non-Operating Interest Income
2
6
7
7
7
52
Minority Interest Expense
-
-
1
21
39
44

About Yifan Pharmaceutical Co.

View Profile
Address
No. 50 Qinshan
Hangzhou Zhejiang 311300
China
Employees -
Website http://www.xinfupharm.com
Updated 07/08/2019
Yifan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products. It focuses on pharmaceutical products, raw materials, and polymer materials. The pharmaceutical products include antibiotics, cardiovascular and cerebrovascular, skin, gynecology, pediatric, blood tumor, and treatment of large infusion.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.